Peptide Library

PT-141

Bremelanotide

Melanocortin receptor agonist with an FDA-approved indication in premenopausal women; other uses discussed with providers.

Provider Determines Testing
Provider Evaluation Required

Meet with one of our licensed medical providers to determine whether peptide therapy is appropriate for you. If clinically appropriate, we'll create a personalized treatment plan and coordinate your care through appropriate pharmacy channels in accordance with applicable laws and regulations.

  • Licensed medical provider evaluation
  • Individualized treatment plan
  • Ongoing clinical support
Quick Answer

PT-141 is Melanocortin receptor agonist with an FDA-approved indication in premenopausal women; other uses discussed with providers. Whether it is appropriate depends on your medical history, goals, current medications, and testing — evaluated by a licensed VidaVital Medical provider during a live consultation. Educational content only; not medical advice.

Key Takeaways
  • PT-141 is sometimes discussed off-label.
  • Your provider determines whether testing is needed.
  • Providers may evaluate it in sexual-wellness.
  • A licensed VidaVital provider must complete a live consultation before any treatment is prescribed.

What is it?

Melanocortin receptor agonist with an FDA-approved indication in premenopausal women; other uses discussed with providers. A licensed provider reviews suitability, monitoring, and any needed testing during a live consultation.

What may it support?

  • Sexual desire research
  • Erectile response research

Where might it fit?

beginner pathwayintermediate pathwaysexual wellness

Bloodwork & monitoring

Baseline status
Provider Determines Testing
The provider determines follow-up cadence individually.
The provider determines final requirements.

Potential side effects

  • Injection-site reaction
  • Mild GI discomfort
  • Rare allergic reaction

Who may not be a candidate?

  • • Uncontrolled hypertension
  • • Cardiovascular disease

Drug interactions

  • • Providers review all medications during consultation

Regulatory disclosures

FDA-approved for hypoactive sexual desire disorder in premenopausal women; other uses are off-label.

The medication is FDA-approved for one or more uses, but the use discussed on this page may not be included in its FDA-approved labeling. A licensed provider may consider an off-label use when medically appropriate.

Speak With a Licensed Medical Provider

If you're interested in learning whether PT-141 may be appropriate for your health goals, schedule a consultation with a licensed VidaVital Medical provider. Your provider will review your medical history, discuss available treatment options, and determine whether any therapy is clinically appropriate for your individual needs.

A licensed VidaVital Medical provider must complete a live video consultation before determining whether this treatment is medically appropriate.

Frequently asked questions

Do I need bloodwork first?
Your provider decides during your live consultation.
Will VidaVital prescribe this to me?
Only if a licensed provider determines it is medically appropriate after a full evaluation.

Sources

  • Provider-reviewed clinical summary — reviewed 2026-01-15 by VidaVital Medical

Related therapies

Interested in PT-141?

Meet with one of our licensed medical providers to determine whether it's appropriate for you.

If clinically appropriate, we'll create a personalized treatment plan and coordinate your care through appropriate pharmacy channels in accordance with applicable laws and regulations.

  • Personalized evaluation
  • Licensed medical provider review
  • Individualized treatment plan
  • Ongoing clinical support
Request Consultation
The information on this website is for educational purposes and does not constitute medical advice, diagnosis, or a prescription. Treatment eligibility, medication selection, dosing, laboratory requirements, and follow-up care are determined exclusively by a licensed medical provider after a live consultation and review of the patient's medical history.